Daniela Taverna

5PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMicro-manipulationMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 20, 2023
p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells.

Giorgia Centonze, Dora Natalini, Silvia Grasso

|May 11, 2023
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response.

Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella

|Jun 30, 2022
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia.

Mohammad Houshmand, Nicoletta Vitale, Francesca Orso

|Mar 29, 2022
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression.

Lorena Quirico, Francesca Orso, Stefania Cucinelli

|May 08, 2021
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation.

Federico Virga, Federica Cappellesso, Benoit Stijlemans

Pageof 1

Frequent Collaborators

2 joint publications

Paola Defilippi

2 joint publications

Francesca Orso

2 joint publications

Giorgia Centonze

2 joint publications

Vincenzo Salemme